Positive Airway Pressure for Obstructive Sleep Apnea in Pregnancy: A Comprehensive Review

Abstract

Obstructive sleep apnea (OSA) is a common condition during pregnancy, affecting a significant proportion of expectant mothers. It is characterized by recurrent episodes of partial or complete upper airway obstruction during sleep, leading to intermittent hypoxia and sleep fragmentation. OSA during pregnancy is independently associated with an increased risk of several complications, including gestational hypertension, preeclampsia, gestational diabetes, and adverse pregnancy outcomes such as preterm birth and low birth weight.

This review provides a comprehensive overview of the current status of positive airway pressure (PAP) therapy for managing OSA in pregnant women. We discuss the pathophysiology of OSA in pregnancy, the benefits and challenges of PAP therapy, and the evidence supporting its use in improving maternal and fetal health outcomes.

Introduction

The prevalence of OSA significantly increases during pregnancy, attributed to hormonal changes, weight gain, and fluid retention. Undiagnosed and untreated OSA poses substantial risks to both mother and fetus. Timely diagnosis and intervention are crucial for mitigating these risks and improving pregnancy outcomes.

PAP Therapy for OSA in Pregnancy

PAP therapy, specifically continuous positive airway pressure (CPAP) and bi-level positive airway pressure (BiPAP), are the gold standard treatments for OSA. They work by delivering pressurized air through a mask, preventing airway collapse during sleep.

Studies have demonstrated the effectiveness of PAP therapy in pregnant women with OSA, showing improvements in:

Maternal blood pressure * Blood sugar control* Sleep quality* Daytime function

Furthermore, PAP therapy has been linked to a reduction in the incidence of preeclampsia, preterm birth, and low birth weight.

Challenges and Considerations

While PAP therapy is generally safe and effective, certain challenges and considerations exist when applying it during pregnancy, including:

Patient adherence and comfort with the mask* Nasal congestion due to pregnancy-related rhinitis* Adjustment of pressure settings as the pregnancy progresses

Conclusion

PAP therapy is a valuable tool for managing OSA in pregnant women, offering significant benefits for both maternal and fetal health. This review emphasizes the importance of raising awareness among healthcare professionals about the prevalence and impact of OSA during pregnancy. Early diagnosis, appropriate referral, and timely initiation of PAP therapy can significantly improve outcomes for both mother and child.

Positive Airway Pressure for Obstructive Sleep Apnea in Pregnancy: A Comprehensive Review